Advisory Services Network’s Axsome Therapeutics AXSM Stock Holding History

Advisory Services Network’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.9K	Buy	+325	New	+$56.1K	﹤0.01%	2565
2025 Q4	–	Sell	-330	Closed	-$40.1K	–	2003
2025 Q3	$40.1K	Buy	+330	New	+$37.2K	﹤0.01%	2565
2024 Q1	–	Sell	-770	Closed	-$61.3K	–	1627
2023 Q4	$61.3K	Buy	+770	New	+$51.5K	﹤0.01%	1900
2023 Q2	–	Sell	-1,333	Closed	-$82.2K	–	1618
2023 Q1	$82.2K	Sell	1,333 -75	-5%	-$4.93K	﹤0.01%	1753
2022 Q4	$109K	Buy	+1,408	New	+$84.2K	﹤0.01%	1562
2021 Q3	–	Sell	-725	Closed	-$49K	–	1538
2021 Q2	$49K	Buy	+725	New	+$43.5K	﹤0.01%	2008
2021 Q1	–	Sell	-725	Closed	-$59K	–	1411
2020 Q4	$59K	Buy	725 +350	+93%	+$26.2K	﹤0.01%	1573
2020 Q3	$27K	Buy	+375	New	+$29.2K	﹤0.01%	1919

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisory Services Network's AXSM Position: Q1 2026 in Review

Advisory Services Network opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 325 shares worth $54.9K. The stake represents ﹤0.01% of the portfolio and ranks #2565 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in AXSM as recently as Q3 2025.

Advisory Services Network first reported a position in AXSM in Q3 2020 and has held it in 8 quarters since. The position peaked at $109K in Q4 2022. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Advisory Services Network held 325 shares of Axsome Therapeutics worth $54.9K as of Q1 2026.
Axsome Therapeutics was a new Advisory Services Network position in Q1 2026.
Axsome Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2565 holding.
Advisory Services Network first reported a position in Axsome Therapeutics in Q3 2020 and has held it in 8 quarters since.
Advisory Services Network's Axsome Therapeutics position peaked at $109K in Q4 2022.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.